Max Robotics — Global Service Robot Directory + US Certification

About

Bryan J. Schneider is a leading oncologist and researcher whose work centers on thoracic malignancies, with a particular focus on lung cancer immunotherapy and targeted treatments. As a co-editor of the *Handbook of Lung Cancer and Other Thoracic Malignancies* (2016), he has helped shape clinical practice by synthesizing cutting-edge research into accessible guidance for practitioners. Schneider’s major contributions lie in elucidating the role of immune checkpoint inhibitors and biomarkers in non-small cell lung cancer, advancing personalized therapeutic strategies that improve patient outcomes. His research has been cited over 4,000 times, reflecting its profound impact on the field. Notably, he has been instrumental in clinical trials exploring combination immunotherapies and resistance mechanisms, earning recognition as a thought leader in precision oncology. Through his work at the University of Michigan Rogel Cancer Center, Schneider continues to bridge laboratory discoveries and bedside care, mentoring the next generation of clinician-scientists while driving innovations that redefine standards for lung cancer treatment.